Zobrazeno 1 - 10
of 409
pro vyhledávání: '"Hobbs, FDR"'
Autor:
Goyder, CR, Roalfe, A, Jones, NR, Taylor, KS, Plumptre, CD, James, O, Fanshawe, T, Hobbs, FDR, Taylor, C
Publikováno v:
ESC Heart Failure. 10:1643-1655
Aims:Heart failure (HF) is a global health burden and new strategies to achieve timely diagnosis and early intervention are urgently needed. Natriuretic peptide (NP) testing can be used to screen for left ventricular systolic dysfunction (LVSD), but
Autor:
Nicholson BD, Aveyard P, Hamilton W, Bankhead CR, Koshiaris C, Stevens S, Hobbs FDR, Perera R
Publikováno v:
Clinical Epidemiology, Vol Volume 11, Pp 145-155 (2019)
Brian D Nicholson,1 Paul Aveyard,1 Willie Hamilton,2 Clare R Bankhead,1 Constantinos Koshiaris,1 Sarah Stevens,1 Frederick DR Hobbs,1 Rafael Perera1 1Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX26GG, UK; 2Colle
Externí odkaz:
https://doaj.org/article/6085a6fefd6d458591363339ee879233
Autor:
Nicholson, BD, Thompson, MJ, Hobbs, FDR, Nguyen, M, McLellan, J, Green, B, Chubak, J, Oke, JL
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 13:2492-2503
Background Unexpected weight loss is a presenting feature of cancer in primary care. Data from primary care are lacking to quantify how much weight loss over what period should trigger further investigation for cancer. This research aimed to quantify
Autor:
Carl Heneghan, Jeffrey K Aronson, Georgia C. Richards, Hobbs Fdr., Brian MacKenna, Ben Goldacre
Publikováno v:
Drug Safety. 45:237-247
IntroductionOpioid prescribing trends have been investigated in many countries. However, the patterns of over-the-counter purchases of opioids without a prescription, such as codeine combinations, are mostly unknown.ObjectiveWe aimed to assess nation
Autor:
Jowett, S, Kodabuckus, S, Ford, GA, Hobbs, FDR, Lown, M, Mant, J, Payne, R, McManus, RJ, Sheppard, JP
Publikováno v:
Jowett, S, Kodabuckus, S, Ford, G A, Hobbs, F D R, Payne, R A & Sheppard, J P 2022, ' Cost-effectiveness of antihypertensive deprescribing in primary care : a Markov modelling study using data from the OPTiMISE trial ', Hypertension, vol. 79, no. 5, pp. 1122-1131 . https://doi.org/10.1161/HYPERTENSIONAHA.121.18726
Background: Deprescribing of antihypertensive medications for older patients with normal blood pressure is recommended by some clinical guidelines, where the potential harms of treatment may outweigh the benefits. This study aimed to assess the cost-
Autor:
Stevenson, DJ, Avery, AJ, Coupland, C, Hobbs, FDR, Kendrick, D, Moore, MV, Morris, C, Rubin, GP, Smith, MD, Hawkey, CJ, Dumbleton, JS
Background The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruited participa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6cacf51f9e31d09d970d8d7cd71bd98
Autor:
Visseren, Flj, Mach, F, Smulders, Ym, Carballo, D, Koskinas, Kc, Back, M, Benetos, A, Biffi, A, Boavida, Jm, Capodanno, D, Cosyns, B, Crawford, C, Davos, Ch, Desormais, I, Di Angelantonio, E, Franco, Oh, Halvorsen, S, Hobbs, Fdr, Hollander, M, Jankowska, Ea, Michal, M, Sacco, S, Sattar, N, Tokgozoglu, L, Tonstad, S, Tsioufis, Kp, van Dis, I, van Gelder, Ic, Wanner, C, Williams, B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3983::b2973a26d10ad076669755a36ea2c912
http://hdl.handle.net/11697/188994
http://hdl.handle.net/11697/188994
Autor:
Hirst, JA, Taal, M, Fraser, S, Ordonez-Mena, J, O'callaghan, C, McManus, R, Taylor, C, Yang, Y, Ogburn, E, Hobbs, FDR
Background: Decline in kidney function can result in adverse health outcomes. The OxREN study has detailed baseline assessments from 884 participants ≥60 years. Aim: To determine the proportion of participants with decline in estimated glomerular f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::35cf56f9828bb86f6586a1e78cb817f3
https://eprints.soton.ac.uk/453312/
https://eprints.soton.ac.uk/453312/
Autor:
Mahendra G Patel, Yu L-M., Oghenekome Gbinigie, O van Hecke, Hobbs Fdr., Nicholas Berry, Emma Ogburn, Michelle A. Detry, Benjamin R. Saville, S de Lusignan, Christina Saunders, Milensu Shanyinde, Mark Fitzgerald, Gail Hayward, Victoria Harris, Christopher C Butler, Philip Evans, Thomas Npb., Monique Andersson, Jienchi Dorward, Duncan Richards
ObjectivesColchicine has been proposed as a COVID-19 treatment, but its effect on time to recovery is unknown. We aimed to determine whether colchicine is effective at reducing time to recovery and COVID-19 related hospitalisations/deaths among peopl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8790dc2724d540da86421fa99f4147d2
https://ora.ox.ac.uk/objects/uuid:bee7b469-2dc6-480e-a3b3-94315143fbee
https://ora.ox.ac.uk/objects/uuid:bee7b469-2dc6-480e-a3b3-94315143fbee
Publikováno v:
European Journal of Heart Failure
© 2019 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. Aim: To provide reliable survival estimates for people with chronic heart failure and explain variation in survival